정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2354 | Recruiting | A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19) | Coronavirus | Drug: PTC299 Other: SOC Drug: Placebo |
Phase 3 | PTC Therapeutics | INDUSTRY | 380 | All | 18 Years | University of California, Irvine, Orange, California, United States Augusta University, Augusta, Georgia, United States Johns Hopkins Hospital, Baltimore, Maryland, United States University of Massachusetts Memorial Health Care, Worcester, Massachusetts, United States University Hospitals Cleveland, Cleveland, Ohio, United States Ralph H. Johnson VA Medical Center, Charleston, South Carolina, United States Westmead Hospital, Westmead, New South Wales, Australia Monash Medical Centre, Clayton, Victoria, Australia Sunshine Hospital, St. Albans, Victoria, Australia St. Pierre University Hospital, Brussels, Belgium Clinique Saint Pierre, Ottignies, Belgium Hospital Vera Cruz, Belo Horizonte, MG, Brazil Hospital Moinhos de Vento, Porto Alegre, RS, Brazil Centro Hospitalar Unimed (CHU) - Joinville, Joinville, SC, Brazil Hospital Guilherme Alvaro, Santos, SP, Brazil Hospital Santa Casa de Misecordia de Sorocoba, Sorocaba, SP, Brazil Hospital Alemao Oswaldo Cruz, Sao Paulo, SP, Brazil Escola Paulista de Medicina (UNIFESP), Sao Paulo, SP, Brazil Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto, Sao Paulo, SP, Brazil Fundacion Santa Fe de Bogota, Bogota, Colombia Centro Cardiovascular Somer Incare, Rionegro, Colombia Hopital Pitie-Salpetriere, Paris, France Centro Hospitalario MAC, Irapuato, Guanajuato, Mexico Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico Integra RGH Centro de Investigacion/ Hospital MAC Puebla, Puebla, Mexico SOMECO - Sociedad de Metabolismo y Corazon S.C., Veracruz, Mexico Central Clinic Hospital of the MSWiA in Warsaw, Warsaw, Poland Centro Hospitalar Universitario de Lisboa Norte (CHULN), E.P.E - Hospital de Santa Maria, Lisboa, Portugal Centro Hospitalar de Entre o Douro e Vouga, EPE (CHEDV), Santa Maria da Feira, Portugal Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE (CHVNG/E), Vila Nova de Gaia, Portugal Worthwhile Clinical Trials, Benoni, South Africa TREAD Research, Cape Town, South Africa Tiervlei Trial Centre, Cape Town, South Africa Ahmed Al-Kadi Private Hospital, Durban, South Africa Global Clinical Trials, Pretoria, South Africa Hospital Del Mar, Barcelona, Spain Hospital Universitario de Bellvitge, Barcelona, Spain Hospital Universitario Infanta Leonor, Madrid, Spain Hospital Universitario Ramon y Cajal, Madrid, Spain Hospital 12 de Octubre, Madrid, Spain Hospital Universitario Infanta Sofia, San Sebastian de los Reyes, Spain |
| 2353 | Active, not recruiting | A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 | SARS-CoV-2 | Biological: mRNA-1273 Biological: Placebo |
Phase 3 | ModernaTX, Inc., Biomedical Advanced Research and Development Authority, National Institute of Allergy and Infectious Diseases (NIAID) | INDUSTRY | 30420 | All | 18 Years | Ascension St. Vincent Birmingham, Birmingham, Alabama, United States Synexus Clinical Research US, Inc. - Birmingham, Birmingham, Alabama, United States Hope Research Institute, Chandler, Arizona, United States Synexus Clinical Research US, Inc. - Phoenix West, Glendale, Arizona, United States Hope Research Institute, Peoria, Arizona, United States Hope Research Institute, Phoenix, Arizona, United States Quality of Life Medical and Research Center, Tucson, Arizona, United States Baptist Health Center for Clinical Research, Little Rock, Arkansas, United States Advanced Clinical Research - Rancho Paseo, Banning, California, United States University of California San Diego, La Jolla, California, United States eStudySite - La Mesa, La Mesa, California, United States UCLA Vine Street Clinic CRS, Los Angeles, California, United States VA Greater Los Angeles Healthcare (veterans only), Los Angeles, California, United States Paradigm Clinical Research Institute Inc, Redding, California, United States Benchmark Research - Sacramento, Sacramento, California, United States Medical Center For Clinical Research - M3 Wake Research, San Diego, California, United States University of Colorado Hospital, Aurora, Colorado, United States Lynn Institute of The Rockies, Colorado Springs, Colorado, United States George Washington University, Washington, District of Columbia, United States Accel Research Site, DeLand, Florida, United States Research Centers of America, Hollywood, Florida, United States Jacksonville Center for Clinical Research, Jacksonville, Florida, United States Synexus - Optimal Research - Melbourne, Melbourne, Florida, United States Suncoast Research Group, Miami, Florida, United States University of Miami, Miami, Florida, United States Synexus Clinical Research US, Inc. - Orlando, Orlando, Florida, United States Palm Beach Research Center, West Palm Beach, Florida, United States Grady Health System, Atlanta, Georgia, United States Children's Healthcare of Atlanta, Atlanta, Georgia, United States Hope Clinic of The Emory Vaccine Center, Decatur, Georgia, United States Meridian Clinical Research, Savannah, Georgia, United States Clinical Research Atlanta, Stockbridge, Georgia, United States Synexus Clinical Research US, Inc. - Chicago, Chicago, Illinois, United States UIC Project WISH CRS, Chicago, Illinois, United States University of Chicago-Hospital, Chicago, Illinois, United States Johnson County Clin-Trials, Lenexa, Kansas, United States Alliance for Multispecialty Research, Newton, Kansas, United States Alliance for Multispecialty Research- East Wichita, Wichita, Kansas, United States Meridian Clinical Research, Baton Rouge, Louisiana, United States Benchmark Research - Metairie, Metairie, Louisiana, United States University of Maryland School of Medicine, Baltimore, Maryland, United States Synexus - Optimal Research - Rockville, Rockville, Maryland, United States Meridian Clinical Research, Rockville, Maryland, United States Brigham and Women's Hospital, Boston, Massachusetts, United States Henry Ford Health System, Detroit, Michigan, United States MediSync Clinical Research Hattiesburg Clinic, Petal, Mississippi, United States Saint Louis University, Saint Louis, Missouri, United States Sundance Clinical Research, Saint Louis, Missouri, United States Meridian Clinical Research, Grand Island, Nebraska, United States Meridian Clinical Research, Norfolk, Nebraska, United States Meridian Clinical Research, Omaha, Nebraska, United States Clinical Research Center of Nevada, Las Vegas, Nevada, United States AB Clinical Trials, Las Vegas, Nevada, United States Hackensack University Medical Center, Hackensack, New Jersey, United States New Jersey Medical School, Newark, New Jersey, United States Meridian Clinical Research, Binghamton, New York, United States Weill Cornell Chelsea - (CRS), New York, New York, United States Weill Cornell Medical College, New York, New York, United States University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States Tryon Medical Partners, Charlotte, North Carolina, United States Carolina Institute for Clinical Research - M3 Wake Research, Fayetteville, North Carolina, United States M3 Wake Research, Inc - M3 Wake, Raleigh, North Carolina, United States Trial Management Associates, Wilmington, North Carolina, United States Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States Synexus Clinical Research US, Inc. - Cincinnati, Cincinnati, Ohio, United States New Horizons Clinical Research, Cincinnati, Ohio, United States Cincinnati CRS, Cincinnati, Ohio, United States Rapid Medical Research Inc, Cleveland, Ohio, United States Lynn Health Science Institute, Oklahoma City, Oklahoma, United States Crisor, Medford, Oregon, United States University of Pennsylvania, Philadelphia, Pennsylvania, United States UPMC University Center, Pittsburgh, Pennsylvania, United States Keystone VitaLink Research, Anderson, South Carolina, United States Keystone VitaLink Research - Greenville, Greenville, South Carolina, United States Coastal Carolina Research Center, Mount Pleasant, South Carolina, United States Keystone VitaLink Research - Spartanburg, Spartanburg, South Carolina, United States Meridian Clinical Research, Dakota Dunes, South Dakota, United States WR-ClinSearch, Chattanooga, Tennessee, United States Alliance for Multispecialty Research, Knoxville, Tennessee, United States Vanderbilt University Medical Center, Medical Arts Building, Nashville, Tennessee, United States Vanderbilt University Medical Center, Medical Center North, Nashville, Tennessee, United States Benchmark Research - Austin, Austin, Texas, United States Synexus - Optimal Research - Austin, Austin, Texas, United States Tekton Research, Austin, Texas, United States Advanced Clinical Research - Be Well MD, Cedar Park, Texas, United States Global Medical Research - M3 Wake Research, Dallas, Texas, United States Synexus Clinical Research US, Inc. - Dallas, Dallas, Texas, United States Benchmark Research - Fort Worth, Fort Worth, Texas, United States University of Texas Medical Branch at Galveston, Galveston, Texas, United States Baylor College of Medicine, Houston, Texas, United States DM Clinical Research - Texas Center For Drug Development, Houston, Texas, United States Laguna Clinical Research, Laredo, Texas, United States Centex Studies, McAllen, Texas, United States Benchmark Research - San Angelo, San Angelo, Texas, United States Clinical Trials of Texas, Inc, San Antonio, Texas, United States DM Clinical Research, Tomball, Texas, United States Synexus Clinical Research US, Inc. - Salt Lake City, Murray, Utah, United States Foothill Family Clinic - North, Salt Lake City, Utah, United States Foothill Family Clinic-South Clinic, Salt Lake City, Utah, United States Kaiser Permanente - Seattle, Seattle, Washington, United States |
| 2352 | Not yet recruiting | A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 Against COVID-19 in Adults | Covid19 Vaccine | Biological: MVC-COV1901 Biological: AZD1222 |
Phase 3 | Medigen Vaccine Biologics Corp. | INDUSTRY | 1020 | All | 18 Years | |
| 2351 | Active, not recruiting | A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents | Covid19 Vaccine | Biological: MVC-COV1901(S protein with adjuvant) Biological: MVC-COV1901(Saline) |
Phase 2 | Medigen Vaccine Biologics Corp. | INDUSTRY | 399 | All | 12 Years ~ 18 Years | Mackay Memorial Hospital Hsinchu, Hsinchu, Taiwan Chang-Guang Memorial Hospital Lin-Kou, Taipei, Taiwan MacKay Memorial Hospital, Taipei, Taiwan National Taiwan University Hospital-HsinChu, Taipei, Taiwan National Taiwan University Hosptial, Taipei, Taiwan |
| 2350 | Active, not recruiting | A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult | Covid19 Vaccine | Biological: MVC-COV1901(S protein with adjuvant) Biological: MVC-COV1901(Saline) |
Phase 2 | Medigen Vaccine Biologics Corp. | INDUSTRY | 3854 | All | 20 Years | Changhua Christian Hospital, Changhua, Taiwan Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan China Medical University Hospital, Taichung, Taiwan National Cheng Kung University Hospital, Tainan, Taiwan National Taiwan University Hospital, Taipei, Taiwan Taipei Medical University Hospital, Taipei, Taiwan Taipei Municipal Wan Fang Hospital, Taipei, Taiwan Taipei Veteran General Hospital, Taipei, Taiwan Tri-Service General Hospital, Taipei, Taiwan Chang-Guang Memorial Hospital Lin-Kou, Taoyuan, Taiwan Tao-Yuan General Hospital, Taoyuan, Taiwan National Institute of Hygiene and Epidemiology, Hanoi, Vietnam |
| 2349 | Active, not recruiting | A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults | Covid19 Vaccine | Biological: MVC-COV1901 (High-Dose) Biological: MVC-COV1901(Mid-Dose) |
Phase 2 | Medigen Vaccine Biologics Corp. | INDUSTRY | 420 | All | 65 Years | Hualien Tzu Chi Hospital, Hualien City, Taiwan Shuang H Hospital, New Taipei City, Taiwan National Taiwan University Hospital, Taipei, Taiwan Chang Gung Medical Hospital Linkou, Taoyuan, Taiwan |
| 2348 | Active, not recruiting | A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients | COVID-19 | Drug: OP-101 Drug: Placebo |
Phase 2 | Orpheris, Inc. | INDUSTRY | 24 | All | 18 Years | Research Site, Loma Linda, California, United States Research site, Fort Lauderdale, Florida, United States Research Site, Atlanta, Georgia, United States Research site, Baltimore, Maryland, United States Research Site, Sioux Falls, South Dakota, United States Research Site, Houston, Texas, United States |
